NCT02467426
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +11 more
- Locations
-
Not specified
Clinical trial condition
Mesothelioma
Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.
141 public trials
37 recruiting studies
Mesothelioma trial results
NCT00325494
- Conditions
- Adenoma, Adnexal Diseases, Bronchial Neoplasms, +32 more
- Locations
-
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- National Cancer Institute Bethesda, Maryland, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT02029105
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +5 more
- Locations
-
- ESOGU Lung and Pleural Cancer Application and Research Center Eskişehir, Turkey (Türkiye)
NCT00787410
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +11 more
- Locations
-
Not specified
NCT00137826
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +3 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00407459
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +3 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, Milan, Italy
NCT00423254
- Conditions
- Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
- Locations
-
- Arizona Cancer Center Tuscon, Arizona, United States
- Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States
- H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
- Nevada Cancer Institute Sparks, Nevada, United States
Completed
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
NCT00316225
- Conditions
- Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hanover, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain
NCT00190762
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9:00 AM - 5:00 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician Ottawa, Ontario, Canada
NCT00061477
- Conditions
- Adenoma, Mesothelioma, Neoplasms, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States